Genialis, Inc.

SEC filing

Biotechnology · Boston, MA

Form D on EDGAR

Amount raised$700Ksold at filing

Total offering$3M$2.3M still open

Investors in the raise2count reported to the SEC

FiledDec 31, 2025first sale Dec 17, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Ita LuDirector

Cedric Hermann OdjeDirector

Elia Hermann StupkaDirector

Krista McKerracherDirector

Miha StajdoharExecutive Officer, Director

Rafael RosengartenExecutive Officer, Director

Luka AusecExecutive Officer

Executive officers, directors and promoters as listed on the Form D.